IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 224 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16 | -33.3% | 3,681 | +4.1% | 0.00% | – |
| Q2 2023 | $24 | +20.0% | 3,535 | +3.3% | 0.00% | – |
| Q1 2023 | $20 | +17.6% | 3,421 | +25.7% | 0.00% | – |
| Q4 2022 | $17 | -99.9% | 2,722 | -22.1% | 0.00% | – |
| Q3 2022 | $32,000 | -13.5% | 3,492 | +0.5% | 0.00% | – |
| Q2 2022 | $37,000 | -32.7% | 3,474 | +3.5% | 0.00% | – |
| Q1 2022 | $55,000 | +19.6% | 3,357 | +38.5% | 0.00% | – |
| Q4 2021 | $46,000 | -4.2% | 2,423 | +21.3% | 0.00% | – |
| Q3 2021 | $48,000 | -37.7% | 1,998 | -33.5% | 0.00% | – |
| Q2 2021 | $77,000 | +7600.0% | 3,006 | +4827.9% | 0.00% | – |
| Q1 2021 | $1,000 | -50.0% | 61 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | – | 61 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |